Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$156,876
+$3,974 QoQ
Shares Held
1,001
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,339
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glen Eagle Advisors, LLC holds $41,817,560 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,724 | $28,882,484 | |
| 2 | ABBV |
AbbVie Inc.
|
21,140 | $5,319,669 | |
| 3 | LLY |
ELI LILLY & Co
|
3,599 | $4,316,748 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,886 | $1,141,851 | |
| 5 | PFE |
Pfizer Inc
|
30,849 | $742,843 | |
| 6 | AMGN |
Amgen Inc
|
1,750 | $633,710 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,641 | $267,414 | |
| 8 | GSK |
GSK plc
|
4,548 | $238,406 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $156,876 | 1,001 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $152,902 | 1,001 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $138,007 | 1,001 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $129,394 | 1,009 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $122,099 | 1,009 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $113,486 | 1,018 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $101,202 | 1,040 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $119,620 | 1,040 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $110,718 | 1,040 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $100,599 | 1,040 | Shares | Sole | 2024-07-03 | |
| 2023-12-31 | $99,960 | 990 | Shares | Sole | 2024-08-13 | |
| 2023-09-30 | $28,317 | 278 | Shares | Sole | 2024-08-13 | |
| 2023-06-30 | $28,153 | 279 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | $25,576 | 278 | Shares | Sole | 2024-08-13 | |
| 2022-12-31 | $32,024 | 353 | Shares | Sole | 2024-08-13 | |
| 2022-09-30 | $26,831 | 353 | Shares | Sole | 2024-08-13 | |
| 2022-06-30 | $29,839 | 353 | Shares | Sole | 2024-08-13 | |
| 2022-03-31 | $30,975 | 353 | Shares | Sole | 2024-08-13 | |
| 2021-12-31 | $30,876 | 353 | Shares | Sole | 2024-08-13 | |
| 2021-09-30 | $37,046 | 453 | Shares | Sole | 2024-08-13 | |
| 2021-06-30 | $41,331 | 453 | Shares | Sole | 2024-08-13 | |
| 2021-03-31 | $36,158 | 423 | Shares | Sole | 2024-08-13 | |
| 2020-12-31 | $39,943 | 423 | Shares | Sole | 2024-08-13 | |
| 2020-09-30 | $34,784 | 400 | Shares | Sole | 2024-08-13 | |
| 2020-06-30 | $34,936 | 400 | Shares | Sole | 2024-08-13 | |
| 2020-03-31 | $27,208 | 330 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||